AB Science SA

As of December 31, 2024, AB Science SA carries a market capitalization of 57.01M, placing it among publicly traded companies globally. Its enterprise value stands at 67.50M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

AB Science SA's next confirmed earnings release is scheduled for April 23, 2027.

As of December 31, 2024, AB Science SA has 64.64M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, AB Science SA maintains a current ratio of 0.71, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 23, 2026, AB Science SA's stock has declined approximately 52.83% over the past 52 weeks. The 50-day moving average sits at 0.65, while the 200-day moving average is 0.95.

As of December 31, 2024, AB Science SA holds 7.99M in cash and equivalents against 18.47M in total debt, resulting in a net debt position of 9.82M. Total book value stands at -23.75M, with working capital of -5.91M providing operational flexibility.